Name: Recombinant Human CD52 (C-Fc-Avi) Biotinylated
SKU: RPES6215
Availability: OutOfStock

Recombinant Human CD52 (C-Fc-Avi) Biotinylated

(No reviews yet) Write a Review

SKU:

RPES6215

Description

View AllClose

Additional Information

Product Type:	Recombinant Protein
Species:	Human

View AllClose

OverviewProduct Name:Recombinant Human FGL1 (C-Fc-Avi) BiotinylatedProduct Code:RPES6207Size:20µgSpecies:HumanE

OverviewProduct Name:Recombinant Human CA125/MUC16 (C-Fc-Avi) BiotinylatedProduct Code:RPES6261Size:20µgSpecies:Human

OverviewProduct Name:Recombinant Human Siglec-10 (C-Fc-Avi) BiotinylatedProduct Code:RPES6333Size:20µgSpecies:Human

OverviewProduct Name:Recombinant Human BCMA/TNFRSF17 (C-Fc-Avi) BiotinylatedProduct Code:RPES6209Size:20µgSpecies:Human

OverviewProduct Name:Recombinant Human CD3 epsilon/CD3E (C-Fc-Avi) BiotinylatedProduct Code:RPES6280Size:20µgSpecies:Human</

Mol Mass:	30.2 kDa
AP Mol Mass:	38-50 kDa
Tag:	C-Fc-Avi
Purity:	> 95 % as determined by reducing SDS-PAGE.
Endotoxin Level:	< 1.0 EU per μg of the protein as determined by the LAL method.
Bio Activity:	Testing in progress

Sequence:	Gly25-Ser36
Accession:	P31358
Storage:	Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
Shipping:	This product is provided as lyophilized powder which is shipped with ice packs.
Formulation:	Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual.
Reconstitution:	Please refer to the printed manual for detailed information.
Background:	CD52, also known as CAMPATH-1 antigen, HE5, and gp20, is a cell surface glycoprotein that can be targeted to induce immune suppression by complement-mediated cell lysis. CD52 is expressed on lymphocytes, monocytes, monocycte-derived dendritic cells, eosinophils, and neutrophils, as well as on mature spermatozoa and epithelial cells lining the male genital tract. From the clinical point of view this protein is an important target for therapeutic interventions aimed at leukocyte depletion in hematological malignancies and post-transplant immunosuppression. CD52 / CDW52 may play a role in carrying and orienting carbohydrate. It is an unusually good target for complement-mediated cell lysis.